This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Nucleic Acid Isolation. Top assignees: Exact Sciences Corporation, Fsc Laboratories, Inc., Applied Biotech, Inc.. Active years: 2003-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- San Maros, CA (US) (2015)
- San Marcos, CA (US) (2003 - 2023)
Company Filing History:
12 out of 113 
5 out of 5 
1 out of 6 
Years Active: 2003-2025
Areas of Expertise:
Title: John Zeis: Innovator in Nucleic Acid Isolation
Introduction
John Zeis, a talented inventor based in San Marcos, CA, has significantly contributed to the field of biotechnology with an impressive portfolio of 22 patents. His inventions primarily focus on the methods and technologies for isolating nucleic acids, which are crucial for various biological applications, particularly in research and clinical settings.
Latest Patents
Among his latest innovations, John Zeis has developed groundbreaking technology pertaining to the isolation of nucleic acids. This technology presents new methods and kits designed specifically for extracting nucleic acids from challenging samples, such as stool. His advancements in this area provide essential tools for researchers and healthcare professionals working with complex biological specimens, thus enhancing diagnostic capabilities.
Career Highlights
John's career features exciting tenures at prominent companies, including Exact Sciences Corporation and FSC Laboratories, Inc. At Exact Sciences, he played a pivotal role in pushing the boundaries of cancer diagnostics through innovative nucleic acid isolation techniques. His work at FSC Laboratories further demonstrates his commitment to advancing science in the laboratory environment.
Collaborations
Throughout his career, John Zeis has had the opportunity to collaborate with esteemed colleagues such as James P. Light, II, and Keith Kopitzke. These partnerships have allowed for a sharing of knowledge and expertise, resulting in enhanced innovations in the field of biotechnology. Together, they have made significant strides in improving the methodologies surrounding nucleic acid extraction.
Conclusion
John Zeis exemplifies the spirit of innovation within the biotechnology industry. With a remarkable number of patents to his name and ongoing collaborations with distinguished professionals, his contributions to nucleic acid isolation are set to impact research and clinical practices for years to come. His dedication to improving scientific methods continues to inspire future inventors and researchers in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile